Product Images Mirabegron
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Mirabegron NDC 70771-1753 by Zydus Lifesciences Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure - 9dd396b5 4841 483a b63b 63a0e3cea1ae 01
Figure 1 - 9dd396b5 4841 483a b63b 63a0e3cea1ae 02
Figure 2 - 9dd396b5 4841 483a b63b 63a0e3cea1ae 03
Figure 3 - 9dd396b5 4841 483a b63b 63a0e3cea1ae 04
Figure 4 - 9dd396b5 4841 483a b63b 63a0e3cea1ae 05
Figure 5 - 9dd396b5 4841 483a b63b 63a0e3cea1ae 06
Figure 6 - 9dd396b5 4841 483a b63b 63a0e3cea1ae 07
Figure 7 - 9dd396b5 4841 483a b63b 63a0e3cea1ae 08
This text contains data related to mean changes from baseline measurements. The measurements range from 0.00 to -2.00, with various increments in between. There are also references to weeks and different treatments, including a placebo and a drug called mirobegron. It seems to be a comparison between the effects of different doses or treatments on a specific parameter.*
Figure 8 - 9dd396b5 4841 483a b63b 63a0e3cea1ae 09
Mirabegron extended-release tablets, 25mg - 9dd396b5 4841 483a b63b 63a0e3cea1ae 10
Mirabegron extended-release tablets, 50mg - 9dd396b5 4841 483a b63b 63a0e3cea1ae 11
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.